Home » Ventana Acquires Spring BioScience
Ventana Acquires Spring BioScience
Ventana Medical Systems announced it has acquired Spring BioScience, a developer and supplier of next-generation rabbit monoclonal antibodies and other reagents, for $28.9 million in cash.
Ventana also will pay Spring shareholders up to $11.7 million over the next two years as Spring achieves specific scientific milestones, the company said. Spring BioScience will be operated as a wholly owned subsidiary of Ventana, it added.
Ventana said it expects the acquisition to streamline its supply chain, reducing the company’s reliance on external suppliers.
Ventana recently rejected a $3 billion hostile takeover bid from Roche Holding AG.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May